Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA)

Historical Holders from Q4 2022 to Q2 2025

Symbol
ERNA on Nasdaq
CUSIP
114082209
Type / Class
Equity / Common Stock, par value $0.005 per share
Shares outstanding
110M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-25
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cherington Charles 37.9% +15.5% $8.76M $4.46M 41.7M +104% Charles Cherington Jun 9, 2025
Freebird Partners LP 9.9% -0.9% $1.18M $204K 6.21M +20.9% Freebird Partners LP Mar 31, 2025
HALPERN JOHN D 9.6% -3.9% $1.25M $175K 5.97M +16.3% John D. Halpern Mar 31, 2025
Konar Shameek 5.5% $653K 3.44M Shameek Konar Mar 31, 2025
IAF, LLC 5.2% -0.4% $619K $109K 3.26M +21.5% IAF, LLC Mar 31, 2025
Singer Nicholas Jason 4.92% $487K 2.57M Nicholas Jason Singer Dec 31, 2024

Institutional Holders of Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 0 $0 -$264K 0
2025 Q1 1.49M $264K +$76K $0.18 26
2024 Q4 994K $292K +$69.7K $0.29 24
2024 Q3 711K $747K +$337K $1.05 20
2024 Q2 390K $712K -$25K $1.83 19
2024 Q1 10.2K $25.3K +$25.1K $2.40 4
2023 Q4 355K $637K +$42.2K $1.80 18
2023 Q3 331K $728K -$4.86K $2.18 19
2023 Q2 333K $750K -$15.6K $2.26 19
2023 Q1 332K $1.14M +$6.9K $3.40 19
2022 Q4 250K $805K +$608K $3.22 17